Form D · Other Health Care
Neolutions Pharmaceuticals Inc.
Baltimore, MD · CIK 0001533067
Offering snapshot reported Oct 28, 2011 · SEC filing
- Reported sold
- $800 Offering amount: $800
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 22, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2011 | Initial | $800 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167977
Source: Form D, filed Oct 28, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rodney Brady | Director |
| Jeff Courtney | Director, Executive |
| Kevin Jackson | Director |
| Gary Pasternack | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
729 East Pratt Street, Suite 360
Baltimore, MD, 21202
Baltimore, MD, 21202